[
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport PersonnelPLATFORMPROGRAMSSolid TumorsB cell MalignanciesPIPELINEMEDIACO",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport PersonnelPLATFORMPROGRAMSSolid TumorsB cell MalignanciesPIPELINEMEDIACO",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport PersonnelPLATFORMPROGRAMSSolid TumorsB cell MalignanciesPIPELINEMEDIACO",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport PersonnelPLATFORMPROGRAMSSolid TumorsB cell MalignanciesPIPELINEMEDIACO",
    "link": "https://www.luminarytx.com/about-us/",
    "timestamp": "unknown"
  },
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport PersonnelPLATFORMPROGRAMSSolid TumorsB cell MalignanciesPIPELINEMEDIACO",
    "link": "https://www.luminarytx.com/about-us/",
    "timestamp": "unknown"
  },
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport PersonnelPLATFORMPROGRAMSSolid TumorsB cell MalignanciesPIPELINEMEDIACO",
    "link": "https://www.luminarytx.com/about-us/",
    "timestamp": "unknown"
  },
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport PersonnelPLATFORMPROGRAMSSolid TumorsB cell MalignanciesPIPELINEMEDIACO",
    "link": "https://www.luminarytx.com/about-us/",
    "timestamp": "unknown"
  },
  {
    "title": "ABOUT USLeadershipBoard of DirectorsScientistsScientific Advisory BoardSupport Personnel",
    "link": "https://www.luminarytx.com/about-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Leadership",
    "link": "https://www.luminarytx.com/about-us/#leadership",
    "timestamp": "unknown"
  },
  {
    "title": "Board of Directors",
    "link": "https://www.luminarytx.com/about-us/#directors",
    "timestamp": "unknown"
  },
  {
    "title": "Scientists",
    "link": "https://www.luminarytx.com/about-us/#scientists",
    "timestamp": "unknown"
  },
  {
    "title": "Scientific Advisory Board",
    "link": "https://www.luminarytx.com/about-us/#advisoryboard",
    "timestamp": "unknown"
  },
  {
    "title": "Support Personnel",
    "link": "https://www.luminarytx.com/about-us/#supportpersonnel",
    "timestamp": "unknown"
  },
  {
    "title": "PLATFORM",
    "link": "https://www.luminarytx.com/platform/",
    "timestamp": "unknown"
  },
  {
    "title": "PROGRAMSSolid TumorsB cell Malignancies",
    "link": "https://www.luminarytx.com/programs/",
    "timestamp": "unknown"
  },
  {
    "title": "Solid Tumors",
    "link": "https://www.luminarytx.com/programs/#solid-tumors",
    "timestamp": "unknown"
  },
  {
    "title": "B cell Malignancies",
    "link": "https://www.luminarytx.com/programs/#b-cell-malignancies",
    "timestamp": "unknown"
  },
  {
    "title": "PIPELINE",
    "link": "https://www.luminarytx.com/pipeline/",
    "timestamp": "unknown"
  },
  {
    "title": "MEDIA",
    "link": "https://www.luminarytx.com/media/",
    "timestamp": "unknown"
  },
  {
    "title": "CONTACT",
    "link": "https://www.luminarytx.com/contact/",
    "timestamp": "unknown"
  },
  {
    "title": "LUMINARY SPOTLIGHTHomeLUMINARY SPOTLIGHT",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "LUMINARY SPOTLIGHTHomeLUMINARY SPOTLIGHT",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "LUMINARY SPOTLIGHTHomeLUMINARY SPOTLIGHT",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "LUMINARY SPOTLIGHTHomeLUMINARY SPOTLIGHT",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "HomeLUMINARY SPOTLIGHT",
    "link": "https://www.luminarytx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary in the spotlightRead the latest news5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary in the spotlightRead the latest news5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary in the spotlightRead the latest news5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary in the spotlightRead the latest news5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary in the spotlightRead the latest news5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary in the spotlightRead the latest news5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR, 2025Jeff Liter, Chief Executive Officer and",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR, 2025Jeff Liter, Chief Executive Officer and",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "5 May, 2025Luminary was highlighted inCell & Gene Therapy Review.You can read the full articlehere.23 APR, 2025Jeff Liter, Chief Executive Officer and",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "You can read the full articlehere.",
    "link": "https://www.cellgenetherapyreview.com/3975-Featured-Articles/619165-Above-the-noise-Amid-an-immunology-rush-CGT-developers-rise-to-the-occasion/",
    "timestamp": "unknown"
  },
  {
    "title": "You can listen to the discussion between Jeff and BioTech Nation\u2019s host, Dr. Moira Gunnhere.",
    "link": "https://www.biotechnation.com/episodes/beyond-the-one-size-fits-all-cure-jeff-liter-founder-ceo-luminary-therapeutics/transcript",
    "timestamp": "unknown"
  },
  {
    "title": "You can listen to the podcast episodehereor find it in your podcast player by looking for Episode 7 of Patient Innovations Podcast.",
    "link": "https://player.captivate.fm/episode/4a09e197-41df-4b08-aeae-bdfccb363b8e",
    "timestamp": "unknown"
  },
  {
    "title": "Jeff Literwas on Oncology Tubeto discuss Luminary\u2019s novel allogeneic manufacturing platform, two approved INDs, and their solid tumor program. See the",
    "link": "https://oncologytube.com/video/41969/gamma-delta-two-phase-1-inds-approved-announces-jeff-liter-ceo-luminary-therapeutics?channelName=Cancernewsupdate",
    "timestamp": "unknown"
  },
  {
    "title": "Jeff Literwas on the Empowered Patient Podcastto discuss Luminary\u2019s novel allogeneic manufacturing platform for treating multiple types of solid tumor",
    "link": "https://empoweredpatientradio.com/allogeneic-platform-using-gamma-delta-cells-in-car-t-treatment-for-solid-tumors-with-jeff-liter-luminary-therapeutics",
    "timestamp": "unknown"
  },
  {
    "title": "Jeff Literpresented on Luminary\u2019s unique allogeneic manufacturing platform. Watch the presentationhere.",
    "link": "https://meetingonthemed.com/company-presentations/?n=luminary-therapeutics",
    "timestamp": "unknown"
  },
  {
    "title": "TheMyeloma Investment Fund (MIF), which is a venture philanthropy subsidiary of theMultiple Myeloma Research Foundation (MMRF), announced today that t",
    "link": "https://www.myelomainvestmentfund.org/",
    "timestamp": "unknown"
  },
  {
    "title": "Thepresentationfrom Beau Webber, PhD, will take place at 3:00 PM EST, where Beau will talk about Luminary Therapeutics\u2019 novel Gamma Delta manufacturin",
    "link": "https://gamma-delta-t-therapies.com/speaker/beau-webber/",
    "timestamp": "unknown"
  },
  {
    "title": "The National Cancer Institute\u2019s (NCI) Small Business Innovation Research Development Center selected Luminary Therapeutics to participate in its 2022\u2013",
    "link": "https://sbir.cancer.gov/programseducation/investorinitiatives",
    "timestamp": "unknown"
  },
  {
    "title": "The presentation from Branden Moriarity, PhD, atOCTS USA 2022will take place at 2:00 PM EST.",
    "link": "https://www.oncocelltherapy.com/events/octs-usa",
    "timestamp": "unknown"
  },
  {
    "title": "Jeff will discuss the benefits of a CAR design with three distinct antigens to avoid antigen escape at theCell & Gene Meeting on the Mediterranean.",
    "link": "https://meetingonthemed.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary Therapeutics\u2019 Chief Science Officer and founder, Beau Webber, PhD to present at the 2021Cell & Gene Meeting on the Mesa,October 12, 2021 at 1",
    "link": "https://meetingonthemesa.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary Therapeutics\u2019 CEO and founder, Jeff Liter to present at the third edition of Phacilitate\u2019s Virtual Member-only series,2021 Advanced Therapies",
    "link": "https://www.advancedtherapiesconnect.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Bio-Techne Corporate (NASDAQ: TECH) today announced the signing of a license agreement with Luminary Therapeutics for the use of TcBuster\u2122for the manu",
    "link": "https://www.luminarytx.com/bio-techne-luminary-therapeutics-sign-license-agreement-for-the-development-car-t-cell-therapies/",
    "timestamp": "unknown"
  },
  {
    "title": "Luminary Therapeutics and Case Western Reserve University enter formal collaboration for clinical development of novel BAFF CAR to treat Mantle Cell L",
    "link": "https://www.luminarytx.com/luminary-therapeutics-case-western-reserve-university-enter-collaboration/",
    "timestamp": "unknown"
  }
]